• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:兀琦,杨静依,陈启梅,王安美,孙艺轩,张加余,杨爱琳.华蟾素通过抑制谷胱甘肽合成酶表达诱导肝癌细胞发生铁死亡的作用机制研究[J].药学研究,2024,43(3):214-219,235[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3160次   下载 3298次 本文二维码信息
码上扫一扫!
华蟾素通过抑制谷胱甘肽合成酶表达诱导肝癌细胞发生铁死亡的作用机制研究
兀琦,杨静依,陈启梅,王安美,孙艺轩,张加余,杨爱琳
字体:加大+|默认|缩小-
(滨州医学院药学院,山东 烟台 264003)
摘要:
目的 研究华蟾素(cinobufotalin)通过抑制谷胱甘肽合成酶(glutathione synthetase, GSS)表达诱导肝癌细胞发生铁死亡的作用机制。方法 不同浓度华蟾素(0、2、4、6、8 μg•mL-1)分别与铁螯合剂(deferoxamine, DFO)50 μmol•L-1或还原型谷胱甘肽(Glutathione,GSH) 5 mmol•L-1联合处理肝癌细胞48 h,采用CCK-8检测细胞活性。采用活性氧(Reactive oxygen species, ROS)、丙二醛(malondialdehyde, MDA)和GSH检测试剂盒检测华蟾素(8 μg•mL-1)干预后肿瘤细胞内ROS、MDA和GSH含量。通过实时荧光定量PCR(QRT-PCR)和Western blotting检测华蟾素处理对肝癌细胞GSS表达的影响。并采用RNA干扰技术探究在肝癌细胞中GSS对GSH含量及肝癌细胞增殖的影响。结果 与单独使用华蟾素相比,铁螯合剂DFO能够部分逆转华蟾素对肝癌细胞的增殖抑制作用。与对照组相比,华蟾素干预组能够增加肿瘤细胞内的ROS和MDA含量,降低GSH含量。同时,研究显示GSH能够部分逆转华蟾素对肝癌细胞的增殖抑制作用。深入机制研究发现,华蟾素能够抑制GSS蛋白表达。RNA干扰实验的结果表明,下调GSS蛋白表达能够降低GSH水平。敲低GSS能够削弱DFO对华蟾素增殖抑制的逆转作用,且敲低GSS能够在一定程度上抑制肝癌细胞的生长,并增强华蟾素的增殖抑制作用。结论 华蟾素能够诱导肝癌细胞发生铁死亡,其机制与干预GSS水平有关。该研究为华蟾素临床应用提供理论基础,并对中药抗肿瘤新药开发起到积极的推动作用。
关键词:  华蟾素  肝癌  铁死亡  谷胱甘肽合成酶
DOI:10.13506/j.cnki.jpr.2024.03.002
基金项目:国家自然科学基金青年项目(No.82204693);滨州医学院高层次人才科研启动金项目(No.BY2020KYQD13)
出版日期:2024-03-25
Study on the mechanism of Cinobufotalin inducing ferroptosis of hepatoma cells by inhibiting the expression
WU Qi,YANG Jingyi,CHEN Qimei,WANG Anmei,SUN Yixuan,ZHANG Jiayu,YANG Ailin
(School of pharmacy, Binzhou Medical University, Yantai 264003, China)
Abstract:
Objective To investigate the mechanism of Cinobufotalin in inducing ferroptosis of hepatoma cells by inhibiting the expression of Glutathione synthetase (GSS).Methods Hepatoma cells were treated with different concentrations of Cinobufotalin (0, 2, 4, 6, 8 μg•mL-1) or in combination with Deferoxamine (DFO) 50 μmol•L-1, Glutathione (GSH) 5 mmol•L-1 for 48 h, respectively. CCK-8 was used to detect cell viability. Reactive oxygen species (ROS), Malondialdehyde (MDA) and GSH assay kit were used to detect ROS, MDA, and GSH levels in tumor cells after treatment of Cinobufotalin (8 μg•mL-1). Quantitative Real-time PCR (QRT-PCR) and Western blotting were used to detect the effect of Cinobufotalin on GSS expression in hepatoma cells. RNA interference technology was used to explore the effect of GSS on GSH level and proliferation potential of hepatoma cells.Results Compared with Cinobufotalin treatment alone, the DFO could partially reverse the inhibitory effect of Cinobufotalin on hepatoma cells proliferation. Compared with the control group, the ROS and MDA levels were increased and the GSH level was decreased in Cinobufotalin treatment group. At the same time, the study showed that GSH could partially reverse the inhibitory effect of Cinobufotalin on the proliferation of hepatoma cells. Further mechanism study showed that Cinobufotalin could inhibit the expression of GSS protein. The results of RNA interference experiment showed that depletion of GSS could reduce GSH level, knockdown of GSS could impair the reverse effect of DFO on the proliferation inhibition of Cinobufotalin, and knockdown of GSS could inhibit the growth of hepatoma cells, and enhance the blocking effects of Cinobufotalin on cell proliferation of liver cancer cells. Conclusion Cinobufotalin can induce ferroptosis in hepatoma cells, and the mechanism is related to GSS intervention. This study provides a theoretical basis for the clinical application of Cinobufotalin, and plays an active role in promoting the development of anti-tumor drugs in traditional Chinese medicine.
Key words:  Cinobufotalin  Hepatocellular carcinoma  Ferroptosis  Glutathione synthetase
今日访问量:2656    总访问量:55339172
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司